UNSPSC 51372118: Dihydrocodeine phosphate

This classification denotes the phosphate form of an opioid receptor agonist and opioid with the molecular formula C18H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N9I9HDB855, chemically known as 7, 8-dihydrocodeine but more generally known as dihydrocodeine, which bears US NIH Compound Identifier 3063. European Medicines Agency schedules Dihydrocodeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07138MIG. The term DIHYDROCODEINE is an International Non-Proprietary Name.

UNSPSC 51372118 Dihydrocodeine phosphate is a Commodity code with limited recent activity in state and local procurement. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—does not involve dihydrocodeine phosphate procurement. Instead, Seminole County solicited naloxone and safe drug deactivation systems through competitive sealed bidding in June 2026. The mismatch between the code's nominal scope (a synthetic opioid pharmaceutical) and the actual work being bought suggests this code does not reflect current state and local demand for dihydrocodeine phosphate. State and local health departments and counties typically procure opioid-related products such as naloxone for overdose reversal and addiction treatment support rather than the pharmaceutical compounds this code represents.

Seminole County, Florida represents the sole identifiable recent issuer under this code classification. The naloxone procurement called for 1,900 units and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, with response deadline July 26, 2023. Vendors were required to include delivery and shipping costs, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract term ran two years with a one-year renewal option. The apparent FEMA funding source introduced additional federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. No other state or local opportunities appear in recent activity under this code, indicating minimal market engagement for dihydrocodeine phosphate procurement at the state and local level.